CSF2 and Parkinson disease: Early active immunization programs in PD have demonstrated robust antibody responses in early/very early PD cohorts [14,15], and vaccine-induced antibodies have shown a reduction in CSF α-syn seeding activity ex vivo, indicating target engagement [16].